cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle

Full text for this resource is not available from the Research Repository.

Genders, Amanda ORCID: 0000-0001-7535-4071, Bradley, EA, Rattigan, S and Richards, SM (2011) cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle. American Journal of Physiology - Endocrinology and Metabolism, 301 (2). E342 - E350. ISSN 0193-1849

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/27785
DOI https://doi.org/10.1152/ajpendo.00691.2010
Official URL http://ajpendo.physiology.org/content/301/2/E342
Subjects Historical > FOR Classification > 1101 Medical Biochemistry and Metabolomics
Historical > Faculty/School/Research Centre/Department > Institute of Sport, Exercise and Active Living (ISEAL)
Keywords microvascular blood flow; muscle glucose uptake; zaprinast; insulin resistance
Citations in Scopus 15 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login